Aquaculture for all

FDA Provides $150,000 For Testing In Aquatic Medicine

Crustaceans Health Welfare +5 more

US - The Food and Drug Administration (FDA) have given $150,000 to support studies on the effectiveness of a treatment for fungal disease in walleye and the safety of a medicated feed for shrimp.

The FDA announced that the studies will be funded through grants intended to support development of new animal drugs for minor species or minor uses in major species.

Researchers at the US Geological Survey's Upper Midwest Environmental Sciences Center in La Crosse, Wisconnin, were awarded about $50,000 for a study on the use of hydrogen peroxide to control saprolegniasis, a fungal disease of walleye.

Researchers at the Agrilife Research Mariculture Laboratory in Port Aransas, Texas, were awarded about $100,000 for a study on the use of oxytetracycline in medicated shrimp feed.

The grant programme was established through the Minor Use and Minor Species Animal Health Act of 2004, and Congress appropriated money to support the programme in March 2009. The grants are intended to defray costs of safety or effectiveness testing in development of new animal drugs.

Create an account now to keep reading

It'll only take a second and we'll take you right back to what you were reading. The best part? It's free.

Already have an account? Sign in here